COVID-19: Some clinical questions after the first 4 months

MeSH terms

• Age Factors
• Anti-Inflammatory Agents / therapeutic use*
• Antibodies, Monoclonal, Humanized / therapeutic use
• Antiviral Agents / therapeutic use*
• Betacoronavirus
• COVID-19
• COVID-19 Drug Treatment
• COVID-19 Vaccines
• Comorbidity
• Coronavirus Infections / drug therapy*
• Coronavirus Infections / immunology
• Coronavirus Infections / prevention & control
• Cytokine Release Syndrome / drug therapy*
• Cytokine Release Syndrome / immunology
• Genetic Predisposition to Disease
• Humans
• Lymphohistiocytosis, Hemophagocytic / immunology
• Pandemics / prevention & control
• Pneumonia, Viral / drug therapy*
• Pneumonia, Viral / immunology
• Pneumonia, Viral / prevention & control
• Prognosis
• Risk Factors
• SARS-CoV-2
• Sex Factors
• Superinfection / epidemiology
• Viral Vaccines / therapeutic use